Biofrontera share price logo

Biofrontera

NASDAQ: BFRI

$1.31

+0.07

(+5.72%)

Live

as on

Biofrontera Stock Performance

as on September 19, 2026 at 5:05 am IST

  • Day's Low

    Day's High

    $1.27
    $1.33
    downward going graph

    3.05%

    Downside

    1.53%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.55
    $1.66
    downward going graph

    57.66%

    Downside

    26.72%

    Upside

    downward going graph

Biofrontera share price movements today

Previous Close
$1.24
Open
$1.28
Volume
820.1K
Market Cap
$18.0M
Day's Low - High
$1.27 - $1.33
52 Week Low - High
$0.55 - $1.66

Biofrontera Historical Returns

1 Month Return
-13.89 %
3 Month Return
+ 25.63 %
1 Year Return
+ 43.6 %
3 Year Return
-85.65 %
5 Year Return
0 %

Biofrontera Stock Fundamentals & Key Indicators

Check Biofrontera market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$18.0M

EPS (TTM)

-0.6

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.07

Industry PE ratio

-7.47

PEG Ratio

-0.011992365697464613

EBITDA

-5.6M

Revenue (TTM)

46.2M

Profit Margin

84.45%

Return On Equity TTM

-127.78%

Biofrontera Stock Valuation

Track how Biofrontera P/E has moved over time to understand its valuation trends.

Biofrontera in the last 5 years

  • Overview

  • Trends

Lowest (-30.29x)

December 31, 2022

Industry (-7.47x)

December 31, 2025

Today (-0.55x)

December 31, 2025

Highest (-0.21x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -0.55x

Biofrontera vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Biofrontera with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$18.0MNA-2.0784.45%0.00%
BUY$21.3B148.54%16.5586.14%0.00%
HOLD$19.1B26.23%-47.5834.83%2.82%
BUY$40.0BNA18.7765.57%1.35%
BUY$30.3B-63.21%12.0170.87%2.86%

Stock Returns calculator for Biofrontera Stock including INR - Dollar returns

The Biofrontera stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Biofrontera investment value today

Current value as on today

₹1,64,894

Returns

₹64,894

(+64.89%)

Returns from Biofrontera Stock

₹51,708 (+51.71%)

Dollar Impact

₹13,186 (+13.19%)

Analyst Recommendation on Biofrontera Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Biofrontera. Average target price of $6

Biofrontera Share Price Target

Get share price movements and forecasts by analysts on Biofrontera.

What analysts predicted

78.17%UPSIDE

Target Price

$6

Current Price

$1.31

Analyzed by

8 Analysts

Target

$6.00

Biofrontera target price $6, a slight upside of 78.17% compared to current price of $1.31. According to 8 analysts rating.

Indian Investors' Interest in Biofrontera Stock

Search interest for Biofrontera Stock has increased by 320% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:320% versus previous 30 day period

Biofrontera Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
7
7
9
12
8
9
6
17
10
12
Gross Profit
3
3
4
7
5
6
4
16
8
9
Operating Income
-5
-5
-4
-1
-4
-5
-6
6
-4
0
EBITDA
-8
0
-5
-1
-3
-4
-6
5
-4
0
Interest Expense
1
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-10
0
-5
-1
-4
-5
-6
5
-4
0
Income Tax Expense
0
0
0
0
0
0
0
-
-
0
Net Income
-10
0
-5
-1
-4
-5
-6
5
-4
0
Net Profit Margin
50.06%
44.61%
45.88%
58.02%
61.61%
70.45%
70.44%
94.91%
81.84%
79.92%

Biofrontera Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Mar 2022
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
26
18
24
28
34
37
41
Gross Profit
13
9
11
13
16
18
32
Operating Income
-14
-9
-25
-18
-22
-17
-9
EBITDA
-8
-7
-36
0
-18
-14
-9
Interest Expense
2
2
0
0
0
2
0
Depreciation
0
0
0
1
1
1
0
Income Before Tax
-10
-10
-37
0
-20
-17
-10
Income Tax Expense
0
0
0
0
0
0
0
Net Income
-10
-10
-37
0
-20
-17
-10
Net Profit Margin
52.61%
51.90%
47.13%
47.04%
48.80%
50.12%
78.65%

Biofrontera Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-10
0
-5
-1
-4
-5
-6
5
-4
0
Operating Cash Flow
-3
-4
-1
-1
-4
-3
-3
-2
0
-1
Investing Cash Flow
-
0
-
0
0
0
0
3
0
-
Financing Cash Flow
5
5
0
4
-
8
-
2
-
-
Change in Cash
2
0
-1
3
-4
5
-3
2
0
-1

Biofrontera Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Mar 2022
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-10
-10
-37
0
-20
-17
-10
Operating Cash Flow
-37
-12
-26
-16
-24
-10
-13
Investing Cash Flow
25
-
0
-5
0
0
2
Financing Cash Flow
16
13
43
14
8
14
10
Change in Cash
4
0
16
-7
-15
4
0

Mutual Funds that own Biofrontera Stock

Check out the Mutual Funds with significant holdings in Biofrontera.

Funds
Holdings
Shares Held
Fidelity Concord Street Trust
0.42169%
62631
VANGUARD INDEX FUNDS
0.351822%
52254

Global Institutional Holdings in Biofrontera

Funds
Holdings
Vanguard
0.57%

Biofrontera News & Key Events

  • img

    Today's Timeline - 14 September

    Mon, 07:28 PM

    -

    Biofrontera receives FDA approval for Ameluz, the first PDT drug for superficial basal cell carcinoma in the U.S.

Insights on Biofrontera

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -4.75M → -604.0K (in $), with an average increase of 686.8% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 10.08M → 12.00M (in $), with an average increase of 16.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation Common Stock has given 74.4% return, outperforming this stock by 160.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Viatris Inc. Common Stock has given 73.7% return, outperforming this stock by 30.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, BFRI stock has moved down by -20.0%

About Biofrontera

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
OrganisationBiofrontera
Headquarters660 Main Street, Woburn, MA, United States, 01801
IndustryDrug Manufacturers - Specialty & Generic
CEODr. Hermann Luebbert Ph.D.
E-voting on sharesClick here to vote

Key Management of Biofrontera

Name

Title

Mr. Eugene Frederick Leffler III

Chief Financial Officer

Mr. George P. Jones

Chief Commercial Officer

Ms. Erica F. Gates CPA, M.B.A.

VP of Finance & Principal Accounting Officer

Mr. Jon Lyons M.B.A., Ph.D.

Vice President of Scientific & Medical Affairs

Mr. Daniel Hakansson J.D.

Senior Corporate Counsel

Ms. Samantha Widdicombe

Senior Vice President of Sales & Strategic Accounts

Dr. Hermann Luebbert Ph.D.

CEO, President & Chairman

FAQs

What is Biofrontera share price today?

Biofrontera share price today is $1.31 as on . Biofrontera share today touched a day high of $1.33 and a low of $1.27.

What is the 52 week high and 52 week low for Biofrontera share?

Biofrontera share touched a 52 week high of $1.66 on and a 52 week low of $0.55 on . Biofrontera stock price today i.e. is trending at $1.31,which is 21.08% down from its 52 week high and 136.16% up from its 52 week low.

What is Biofrontera's market capitalisation today?

Biofrontera market capitalisation is $0.00T as on .

How to invest in Biofrontera Stock (BFRI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Biofrontera on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Biofrontera Shares that will get you 1.1450 shares as per Biofrontera share price of $1.31 per share as on September 18, 2026 at 11:35 pm IST.

What is the minimum amount required to buy Biofrontera Stock (BFRI) from India?

Indian investors can start investing in Biofrontera (BFRI) shares with as little as ₹95.8725 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.73 in Biofrontera stock (as per the Rupee-Dollar exchange rate as on ). Based on Biofrontera share’s latest price of $1.31 as on September 18, 2026 at 11:35 pm IST, you will get 7.6336 shares of Biofrontera. Learn more about fractional shares .